App-based diet intervention superior in managing IBS

App-based diet intervention superior in managing IBS

A FODMAP-lowering diet administered through smartphone application was superior to standard medical therapy alone in improved symptom severity among patients with irritable bowel syndrome, according to a presentation at Digestive Disease Week.“In primary care, IBS is a condition that generates high diagnostic and therapeutic uncertainty for general practitioners and the efficacy of currently available therapeutic…

VIDEO: N95 masks protect most against aerosol transmission in the endoscopy suite

VIDEO: N95 masks protect most against aerosol transmission in the endoscopy suite

The endoscopy suite exposes physicians to many breath droplets and amid the COVID-19 pandemic, one study at Digestive Diseases Week showed N95 and KN95 masks provide the most protection from inhaling these droplets.“It does look like respiratory masks protect us in a hospital environment, certainly in an endoscopy unit, which is what I was interested…

Cognitive behavior therapy reduces mood symptoms in patients with functional GI disorders

Cognitive behavior therapy reduces mood symptoms in patients with functional GI disorders

Implementation of a digital cognitive behavioral therapy tool during the COVID-19 pandemic reduced mood symptoms among patients with functional gastrointestinal disorders who also have anxiety or depression.“Patients with functional GI disorders (FGID) exhibit increased sensitivity to stressors which can lead to anxiety and depression. Cognitive behavioral therapy (CBT) is known to help improve mood, increase…

Skyrizi induction therapy bests placebo in refractory Crohn’s

Skyrizi induction therapy bests placebo in refractory Crohn’s

Crohn’s disease previously unresponsive to conventional and biologic therapies showed response to Skyrizi, achieving clinical remission in more than a third of patients regardless of dosing, according to a presentation at Digestive Diseases Week.“In ADVANCE and MOTIVATE, significantly more patients achieved the co-primary endpoints of clinical remission – with different definitions – and endoscopic response…

COVID-19: Innovating health care to work toward hepatitis elimination

COVID-19: Innovating health care to work toward hepatitis elimination

Despite the SARS-CoV-2 pandemic, WHO has not yet changed their elimination targets for viral hepatitis, nor should they.Prepandemic, most countries were significantly off track to achieve the 2030 goals, which has only been exponentially increased by COVID-19. Not only has this sidetracked the target, but the pandemic has also taken cancer screening and preventive strategies…

COVID-19 impacts the global 2030 target to eliminate viral hepatitis

COVID-19 impacts the global 2030 target to eliminate viral hepatitis

Prior to the COVID-19 pandemic, WHO set a target to eliminate viral hepatitis around the world by 2030. But, as focus necessarily turned toward the pandemic, the organization seems to now doubt viral hepatitis elimination goals will be met.The World Hepatitis Alliance (WHA), which represents 300 member organizations from 99 countries, assessed the impact of…

Processed food consumption, IBD diagnosis

Processed food consumption, IBD diagnosis

Increased consumption of processed foods correlated with the development of inflammatory bowel disease, according to a presentation at Digestive Disease Week.“Although there have been many associations reported, there remains many confounding factors that makes the establishment of a clear cause [of IBD] very difficult. Diet has been hypothesized to play an integral role in the…

VIDEO: Imaging plays role in detecting postoperative Crohn’s recurrence

VIDEO: Imaging plays role in detecting postoperative Crohn’s recurrence

In this video exclusive, Benjamin Click, MD, from Cleveland Clinic, discussed the accuracy of imaging for the detection of postoperative Crohn’s disease recurrence.The retrospective study included approximately 900 patients from Cleveland Clinic who underwent ileocecal resection for Crohn’s disease. In addition, they assessed patients with paired imaging and endoscopic assessments within 90 days of each…

Fecal microbiota transplantation safe in patients with psoriatic arthritis

Fecal microbiota transplantation safe in patients with psoriatic arthritis

Fecal microbiota transplantation is safe in patients with psoriatic arthritis, according to data from the first preliminary, randomized trial of the procedure in immune-mediated arthritis.However, data from the albeit small study of 31 patients suggests that fecal microbiota transplantation is inferior to sham surgery, leading the researchers to call for more trials.“Overall, we think that…